13,000 people to benefit from new insulin medicine
Source: PHARMAC Pharmac will fund a new type of insulin for people with diabetes, branded as Ryzodeg, from 1 May 2025. Pharmac’s Director Pharmaceuticals, Geraldine MacGibbon, expects about 13,000* people with diabetes will benefit from this insulin in the first year of funding, increasing to about 18,000 after five years. “Ryzodeg is a combination of … Read more